126 related articles for article (PubMed ID: 7328185)
21. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
[TBL] [Abstract][Full Text] [Related]
22. Antigenemia HBs and other serological markers of hepatitis B virus infection in patients with acute and chronic alcoholism.
Boron P; Sokolewicz-Bobrowska E; Boron-Kaczmarska A; Sidun Z; Pilasiewicz R
Alcohol Alcohol; 1986; 21(3):281-3. PubMed ID: 3768102
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and presentation of hepatitis C related chronic liver disease in southern India.
Issar SK; Ramakrishna BS; Ramakrishna B; Christopher S; Samuel BU; John TJ
J Trop Med Hyg; 1995 Jun; 98(3):161-5. PubMed ID: 7783272
[TBL] [Abstract][Full Text] [Related]
24. Occult hepatitis B virus infection in ART-naive HIV-infected patients seen at a tertiary care centre in north India.
Gupta S; Singh S
BMC Infect Dis; 2010 Mar; 10():53. PubMed ID: 20205948
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of hepatitis B surface antigen (HBsAg), anti-hepatitis B surface (anti-HBs) and anti-hepatitis B core (anti-HBc) in patients with acquired immuno-deficiency syndrome (AIDS).
Ogutu EO; Amayo EO; Okoth F; Lule GN
East Afr Med J; 1990 May; 67(5):355-8. PubMed ID: 2390958
[TBL] [Abstract][Full Text] [Related]
26. [Significance of detailed Hepatitis B virus marker studies in chronic liver diseases].
Horváth G; Tolvaj G; Dávid K
Orv Hetil; 1992 Jul; 133 Suppl 1():9-13. PubMed ID: 1630808
[TBL] [Abstract][Full Text] [Related]
27. Ethnic differences in the incidence of postnecrotic cirrhosis in Israel: correlation with hepatitis B virus serological markers.
Enat R; Ben-Porath E; Joffe B; Baruch J; Lichtig C
Am J Gastroenterol; 1983 Oct; 78(10):656-60. PubMed ID: 6624742
[TBL] [Abstract][Full Text] [Related]
28. [Hepatitis B virus and chronic HBsAg-negative hepatopathies].
Sánchez Tapias JM
Med Clin (Barc); 1984 Mar; 82(12):549-51. PubMed ID: 6738155
[No Abstract] [Full Text] [Related]
29. Hepatitis B virus infection in porphyria cutanea tarda.
Rocchi E; Gibertini P; Cassanelli M; Pietrangelo A; Jensen J; Ventura E
Liver; 1986 Jun; 6(3):153-7. PubMed ID: 3747744
[TBL] [Abstract][Full Text] [Related]
30. [Retrospective review of the prevalence of hepatitis B virus in several population groups].
Salom I; Román S; Macaya G; Fonseca J; Brenes F; Mora C; Martén A
Rev Biol Trop; 1990 Jun; 38(1):83-6. PubMed ID: 2093953
[TBL] [Abstract][Full Text] [Related]
31. [Studies on the serological manifestation of the hepatitis B-virus-infections in the Republic of Liberia (author's transl)].
Neppert J; Gerlich W
Zentralbl Bakteriol Orig A; 1979 Oct; 245(1-2):8-16. PubMed ID: 44626
[TBL] [Abstract][Full Text] [Related]
32. Importance of markers of hepatitis B virus in alcoholic liver disease.
Saunders JB; Wodak AD; Morgan-Capner P; White YS; Portmann B; Davis M; Williams R
Br Med J (Clin Res Ed); 1983 Jun; 286(6381):1851-4. PubMed ID: 6407600
[TBL] [Abstract][Full Text] [Related]
33. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B and hepatitis C virus infection among chronic alcoholic patients with liver disease in Taiwan.
Chang TT; Lin CY; Chow NH; Hsu PI; Yang CC; Lin XZ; Shin JS; Chen DS
J Formos Med Assoc; 1994 Feb; 93(2):128-33. PubMed ID: 7912583
[TBL] [Abstract][Full Text] [Related]
35. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
Ardito D; Bianco T; Demundo T; Loiodice L
Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
[TBL] [Abstract][Full Text] [Related]
36. Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population.
Ma SY; Au WY; Ng IO; Lie AK; Leung AY; Liang RH; Lau GK; Kwong YL
Transplantation; 2003 Jul; 76(1):169-76. PubMed ID: 12865805
[TBL] [Abstract][Full Text] [Related]
37. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of Hepatitis B and C virus infection among alcoholic individuals: importance of screening and vaccination.
Cortes VF; Taveira A; Cruz HM; Reis AA; Cezar JS; Silva BS; D'Assunção CF; Lampe E; Villar LM
Rev Inst Med Trop Sao Paulo; 2017; 59():e47. PubMed ID: 28793018
[TBL] [Abstract][Full Text] [Related]
39. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
40. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
